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Abstract
Background: Thymic stromal lymphopoietin (TSLP) is an interleukin-7 (IL-7) like cytokine, which plays an important
role in the regulation of immune responses to allergens. TSLP binds to a heterodimeric receptor complex
composed of the IL-7 receptor a chain (IL-7Ra) and the TSLP receptor (TSLPR, also known as CRLF2). It has
previously been suggested that the lone tyrosine residue in the mouse TSLPR cytoplasmic domain is required for
cell proliferation using chimeric receptor systems. Also the role of tyrosine residues in the IL-7Ra cytoplasmic
domain in TSLP signaling has not yet been investigated. We undertook a systematic analysis to test the role of
tyrosine residues of both the IL-7Ra and the TSLPR in inducing cell proliferation in a growth factor dependent cell
line, Ba/F3.
Results: A multiple sequence alignment of the IL-7Ra and TSLPR cytoplasmic domains revealed conservation of
most, but not all, cytoplasmic tyrosine residues across several species. Our site-directed mutagenesis experiments
revealed that the single tyrosine residue in human TSLPR was not required for TSLP-dependent cell proliferation. It
has previously been reported that Y449 of human IL-7Ra is required for IL-7 dependent proliferation. Interestingly,
in contrast to IL-7 signaling, none of tyrosine residues in the human IL-7Ra cytoplasmic domain were required for
TSLP-dependent cell proliferation in the presence of a wild type TSLPR. However, the mutation of all cytoplasmic
four tyrosine residues of human IL-7Ra and human TSLPR to phenylalanine residues abolished the proliferative
ability of the TSLP receptor complex in response to TSLP.
Conclusion: These results suggest that TSLP requires at least one cytoplasmic tyrosine residue to transmit
proliferative signals. Unlike other members of IL-2 cytokine family, tyrosine residues in IL-7Ra and TSLPR
cytoplasmic domains play a redundant role in TSLP-mediated cell growth.
Background
Thymic stromal lymphopoietin (TSLP) was first identi-
fied as a growth factor in the conditioned medium
supernatant from the Z210R.1 thymic stromal cell line
to support B cell proliferation in vitro [1,2]. TSLP is
now known to play a key role in the initiation of asthma
[3,4]. TSLP shares IL-7Ra with IL-7. TSLP signaling is
mediated by a heterodimeric receptor complex, which
consists of the interleukin-7 receptor a chain (IL-7Ra)
and a unique TSLP-binding receptor (TSLPR), to trans-
mit proliferative signals in cells [5-7]. IL-7 binds to a
heterodimeric receptor complex, the IL-7Ra and the
cytokine receptor common gamma chain (gc), which is
s h a r e db yI L - 2 ,4 ,7 ,9 ,1 5a n d2 1 .B o t hT S L Pa n dI L - 7
can activate the transcription factor STAT5. In the IL-7
receptor complex, IL-7Ra binds to Jak1 and gc binds to
Jak3 upon addition of IL-7. However, none of Jak
kinases have been reported to be phosphorylated by the
binding of TSLP to its receptor [2]. Previous studies
showed that Y449 in the IL-7Ra cytoplasmic domain
provides a docking site for PI-3K and STAT5 and is
required for a proliferative signal by IL-7 signaling
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reproduction in any medium, provided the original work is properly cited.[8-10]. Further, the tyrosine residues of gc are not
required for IL-7-mediated cell proliferation [11]. Isak-
sen and colleagues observed that the lone tyrosine resi-
due of the mouse TSLPR cytoplasmic domain is
required for TSLP-mediated cell proliferation using chi-
meric receptors composed of the human GM-CSFR a
chain extracellular domain fused to the mouse TSLPR
transmembrane and cytoplasmic domains and the
human GM-CSFR b chain extracellular domain fused to
the mouse IL-7Ra transmembrane and cytoplasmic
d o m a i n s[ 1 2 ] .B r o w ne ta l .s h o w e dt h a ta n t i - I L - 7 R a
antibodies inhibited TSLP-mediated proliferation of pre
B-leukemia [13], indicating that both IL-7Ra and
TSLPR contribute to TSLP-dependent cell proliferation.
We aligned the protein sequences of IL-7Ra and
TSLPR cytoplasmic domains and observed that Y449
and Y456 of human IL-7Ra and Y368 of human TSLPR
were conserved across the species examined while Y401
of human IL-7Ra was not conserved. Because the role
of tyrosine residues in the context of the ‘native’ form
TSLP receptor complex in TSLP-mediated cell prolifera-
tion has not been previously investigated, we took a sys-
tematic approach to evaluate the role of cytoplasmic
tyrosine residues of TSLP receptor complex in mediat-
ing TSLP-induced cell proliferation. Our data show that
the cytoplasmic tyrosine residues of either human IL-
7Ra or human TSLPR can mediate TSLP-induced cell
proliferation and that mutation of all the four cytoplas-
m i ct y r o s i n er e s i d u e so fh u m a nI L - 7 R a and human
TSLPR to phenylalanine residues is required to abolish
TSLP-dependent cell proliferation.
Results and Discussion
Most, but not all, cytoplasmic tyrosine residues of IL-7Ra
and TSLPR are conserved across species
Tyrosine residues in cytokine receptor cytoplasmic
domains play important roles in mediating cytokine sig-
naling and are mostly conserved across species. We
aligned the amino acid sequences of IL-7Ra and TSLPR
cytoplasmic domains from various species. Figure 1A
shows an alignment of the IL-7Ra cytoplasmic domains.
The membrane-proximal domains and C-terminal
regions harboring two tyrosine residues are conserved
among all IL-7Ra chains while the regions in between
vary to some extent. The IL-7Ra cytoplasmic domains
in Mus musculus, Rattus norvegicus,a n dGallus gallus
have four tyrosine residues while the IL-7Ra cytoplas-
mic domains in Homo sapiens, Pan troglodytes, Macaca
mulatta, Canis lupus familiaris and Bos taurus only har-
bor three tyrosine residues. As indicated by red arrows
in Figure 1A, the two tyrosine residues in the C-term-
inal region of the IL-7Ra chains are conserved while
other tyrosine residues in the variable region are not
conserved (red triangles). Figure 1B shows an alignment
of the TSLPR cytoplasmic domains. As observed in the
case of IL-7Ra, the membrane-proximal domains and
C-terminal regions harboring one tyrosine residue are
conserved in all TSLPRs while the intervening regions
are variable. TSLPR cytoplasmic domains in Homo
sapiens, Mus musculus, Rattus norvegicus and Canis
lupus familiaris have only one tyrosine residue while the
TSLPR cytoplasmic domain in Bos taurus harbors two
tyrosine residues. Interestingly, the tyrosine residue in
the C-terminal region of the TSLPR cytoplasmic
domains across species is also conserved (a red arrow in
Figure 1B). Because tyrosine residues play an important
role in mediating the signaling by cytokine receptors
and are conserved in the IL-7Ra and TSLPR cytoplas-
mic domains, we wanted to examine the role of these
tyrosine residues in TSLP-dependent cell proliferation.
The lone cytoplasmic tyrosine residue in TSLPR is not
required for TSLP-dependent cell proliferation
Cytokines IL-2, 4, 7, 9, 15 and 21 share the common
receptor subunit gc that shows high homology to
TSLPR. It has been reported earlier that these cytokines
do not require the tyrosine residues of the gc cytoplas-
mic domain to support cell growth [11]. In contrast,
Isaksen and colleagues reported earlier that the single
tyrosine residue of the mouse TSLPR cytoplasmic
domain is critical for TSLP-dependent cell proliferation
[12]. Because the study was based on a chimeric recep-
tor system, we sought to study the role of tyrosine resi-
dues in TSLP signaling in the context of the native
TSLP receptor complex. TSLP requires the heterodi-
meric TSLP receptor complex - IL-7Ra and TSLPR - to
transmit signals (Figure 2A). Reche et al. have shown
that coexpressed human TSLPR and IL-7Ra receptor
subunits respond to human but not mouse TSLP [7].
We retested the requirement of the receptor complex
for human TSLP-mediated signaling in an IL-3 depen-
dent mouse cell line, Ba/F3, which also expresses endo-
genous murine TSLPR. A retroviral system was used to
generate Ba/F3 cells that express wild type hTSLPR
and/or wild type hIL-7Ra.A ss h o w ni nF i g u r e2 B ,o n l y
Ba/F3 cells expressing both hIL-7Ra and hTSLPR, but
not those expressing hIL-7Ra or hTSLPR alone could
proliferate in response to human TSLP. Cell surface
expression of human TSLPR and human IL-7Ra was
confirmed by flow cytometry analysis using anti-human
TSLPR and anti-human IL-7Ra antibodies (Figure 2C).
These results again confirmed the requirement of hIL-
7Ra and hTSLPR for human TSLP action allowing us to
use this system for a systematic analysis of the require-
ment of tyrosine residues.
Human TSLPR contains only one cytoplasmic tyrosine
residue (Y368) very close to the carboxyl terminus
(Figure 1A). To determine whether this residue is
required for TSLP-mediated cell proliferation, it was
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Page 2 of 11replaced by a phenylalanine residue (Y368F). A Ba/F3
cell line expressing both hTSLPR (Y368F) and hIL7Ra
(WT) was established using retrovirus-based infection.
As shown in Figure 2D and 2E, mutation of this tyrosine
residue failed to abolish the proliferative response to
T S L P .O nd a y3o fc u l t u r e ,1 0 0n g / m lT S L Pi n d u c e d
~25% more proliferation in Ba/F3 cells expressing
hTSLPR (Y368F)/hIL-7Ra (WT) than Ba/F3 cells
expressing hTSLPR (WT)/hIL-7Ra (WT) (p-value <
0.01) (Figure 2D). To examine this in greater detail, we
c a r r i e do u tad o s er e s p o n s es t u d y( F i g u r e2 E ) .W e
observed that in contrast to what was observed at 100
ng/ml, Ba/F3 cells expressing the hTSLPR (Y368F)/hIL-
7Ra ( W T )p a i rg r e wa tas l o w e rr a t e( p - v a l u e<0 . 0 1 )
than Ba/F3 cells expressing the hTSLPR (WT)/hIL-7Ra
(WT) in response to low doses of TSLP (1 ng/ml and
10 ng/ml). There was no statistical difference between
the two at 0.01 ng/ml and 0.1 ng/ml. The cell surface
expression of human TSLPR and human IL-7Ra was
similar across the cell lines as confirmed by FACS using
anti-human TSLPR and anti-human IL-7Ra antibodies
(data not shown). Nevertheless, in contrast to a previous
report using a chimeric receptor system [12], our data
showed that the lone tyrosine residue in the TSLPR
cytoplasmic domain is not required for TSLP-dependent
cell proliferation. Our findings suggest that studies
about TSLP-mediated signaling pathways should be car-
ried out in the context of the native TSLP receptor
complex. Intriguingly, thes ed a t as u g g e s tt h a tY 3 6 8i n
the hTSLPR cytoplasmic domain may play an inhibitory
role in TSLP signaling in response to high doses of
TSLP while playing a positive role at lower doses.
The cytoplasmic tyrosine residues in IL-7Ra are required
for IL-7 but not TSLP-dependent cell proliferation
Like TSLP, the receptor complexes for IL-4, 7, 9 and 21
are all heterodimers. Previous studies showed that Y497
of the human IL-4R is essential for IL-4 mediated prolif-
eration [14] and that Y449 of the human IL-7Ra is
required for IL-7 induced cell growth [8,9]. It has also
been shown that IL-9 requires Y407 of the IL-9R to
transmit proliferative signals and activate STATs [15]
and that Y501 of the IL-21R is critical for maximal
IL-21-mediated proliferation [16]. The human IL-7Ra
contains three tyrosine residues in its cytoplasmic
Figure 1 Conservation of cytoplasmic tyrosine residues in IL-7Ra/TSLPR across species. Sequence alignments of (A) the IL-7Ra
cytoplasmic domains from Mus musculus, Rattus norvegicus, Homo sapiens, Pan troglodytes, Macaca mulatta, Canis lupus familiaris, Bos taurus, and
Gallus gallus and (B) the TSLPR cytoplasmic domains from Homo sapiens, Canis lupus familiaris, Bos taurus, Mus musculus, and Rattus norvegicus
were performed using ClustalX version 2.0.10 with the BLOSUM62 matrix. The conserved amino acid residues are highlighted in yellow while
tyrosine residues are in red; conserved tyrosine residues are indicated by a red arrow.
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Page 3 of 11Figure 2 The lone cytoplasmic tyrosine residue of human TSLPR is not required for TSLP-dependent cell proliferation. (A) A schematic
illustration of the human TSLP receptor complex composed of the human IL-7Ra and the human TSLPR. Y denotes the cytoplasmic tyrosine
residues. (B) Exponentially growing Ba/F3 cells were starved and then treated with human TSLP (100 ng/ml). The data are represented as fold
changes with the number of cells seeded on day 0 (for TSLP stimulation) representing the baseline. The mean of experiments done in triplicate
for each time point and each cell line is shown. Error bars indicate S.E.M. (C) Surface expression of the wild type human TSLPR and IL-7Ra in the
cell lines used in (B). Exponentially growing infected Ba/F3 cells were analyzed by flow cytometry for cell surface expression of human TSLPR
and IL-7Ra. (D) TSLP-induced proliferation of Ba/F3 cells co-expressing the indicated were examined as described in (B). Statistical significance of
the proliferative responses in the different cells at the same time point was evaluated using unpaired Student’s t-test (* indicates a significant
difference with p-value < 0.01). (E). Exponentially growing Ba/F3 cells were starved and then stimulated with the indicated concentration of
human TSLP for 3 days. Cell numbers were counted after 3 days. The data are represented as fold changes with the number of cells seeded on
day 0 (for TSLP stimulation) representing the baseline. Statistical significance of the proliferative responses in the different cells in response to the
same dose of TSLP was evaluated using unpaired Student’s t-test (* indicates a significant difference with p-value < 0.01). (The growth of cells
was examined in 3 independent sets of experiments and found to be similar. The results from one representative experiment are shown).
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Page 4 of 11domain. Because the cytoplasmic tyrosine residue of
human TSLPR is not required for cell proliferation and
cytoplasmic tyrosine residues are critical for cytokine
receptor signaling, we wanted to determine the require-
ment of the tyrosine residues in the IL-7a cytoplasmic
domain for TSLP-dependent cell proliferation. We
replaced the cytoplasmic tyrosine residues in IL-7Ra
with phenylalanine residues to generate IL-7Ra mutants.
First, we generated three individual mutants of human
IL-7Ra- Y401F, Y449F and Y456F. Three Ba/F3 cell
lines expressing the wild type TSLPR along with the
three mutated IL-7Ra were established using retrovirus-
based infection. Interestingly, none of the three muta-
tions in the human IL-7Ra cytoplasmic domain abol-
ished the proliferative response to TSLP administration
(Figure 3). The individual mutations, Y401F (Figure 3A),
Y449F (Figure 3C) and Y456F (Figure 3E), even led
to an enhanced proliferative response at 100 ng/ml
of TSLP. However, at lower doses of TSLP, Y449F
(Figure 3D) and Y456F (Figure 3F), exhibited a dimin-
i s h e dr e s p o n s e( p - v a l u e<0 . 0 1 ) .B e c a u s et h et h r e et y r o -
sine residues in hIL-7Ra may play redundant roles in
supporting cell proliferation, we mutated all of them to
phenylalanine residues (Y401F/Y449F/Y456F) and trans-
duced this mutant receptor into Ba/F3 cells along with
wild type human TSLPR. Strikingly, the mutation of all
three cytoplasmic tyrosine residues of the human
IL-7Ra to phenylalanine residues was still unable to
abolish the proliferative response to TSLP (Figure 3G
and 3H). The cell surface expression of mutant or wild
type hIL-7Ra and hTSLPR was similar as evidenced by
FACS (data not shown).
Because the role of tyrosine residues in human IL-7Ra
cytoplasmic domain in proliferation induced by IL-7,
which requires IL-7Ra and gc (Figure 4A), was estab-
lished in a chimeric receptor system [8,9], we revisited
this issue in Ba/F3 cells. Ba/F3 cells expressing the wild
type or mutant human IL-7Ra (Y401F/Y449F/Y456F)
and the wild type human gc were established and evalu-
ated for cell proliferation upon addition of human IL-7.
In contrast to what we observed with TSLP, mutation
of the three tyrosine residues in IL-7Ra completely
abolished Ba/F3 cell proliferation in response to IL-7
(Figure 4B), which is consistent with previous reports
[8,9]. Cell surface expression of human IL-7Ra and
human gc were similar by FACS using anti-human
IL-7Ra and anti-human gc antibodies (Figure 4C).
Taken together, our data show that the cytoplasmic tyr-
osine residues in IL-7Ra are required for IL-7 but not
TSLP-dependent cell proliferation.
TSLP-dependent cell proliferation requires the presence
of at least one tyrosine residue
We next wanted to test whether any combination of
mutation of tyrosine residues in IL-7Ra or TSLPR could
affect TSLP-induced cell proliferation. For this, we gen-
erated three additional cell lines, hTSLPR (Y368F)/hIL-
7Ra (Y401F), hTSLPR (Y368F)/hIL-7Ra (Y449F) and
hTSLPR (Y368F)/hIL-7Ra (Y456F). As shown in Figure
5A, C and 5E, none of these combinations abolished
cell proliferation in response to TSLP. As observed pre-
viously for individual tyrosine residues in IL-7Ra,c o m -
bining them with TSLPR tyrosine mutants still
led to a diminished response at low doses of TSLP
(p-value < 0.01) (Figure 5B, D and 5F).
To test if any tyrosine residues were required for
TSLP-induced proliferation, we mutated all tyrosine
residues in the TSLP receptor complex (TSLPR
(Y368F)/IL-7Ra (Y401F/Y449F/Y456F)). As shown in
Figure 5G and 5H, this abolished the ability of the
human TSLP receptor complex to drive cell prolifera-
tion. Taken together, our data suggest that TSLP signal-
ing requires at least one tyrosine residue to support
cell growth while all the four tyrosine residues in
human TSLP receptor complex play various roles in
TSLP-mediated cell proliferation.
STAT5 phosphorylation requires at least one cytoplasmic
tyrosine residue in the human TSLP receptor complex
Both human and mouse TSLP can induce STAT5 phos-
phorylation [2,7]. We examined whether TSLP-induced
phosphorylation of STAT5 requires any of the cytoplas-
mic tyrosine residues of human TSLP receptor complex.
As shown in Figure 6, while TSLP induced STAT5
phosphorylation in cells expressing wild type receptors
and those expressing hTSLPR (WT)/hIL7Ra (Y401F/
Y449F/Y456F), no phosphorylation was detectable in
cells expressing hTSLPR (Y368F)/hIL7Ra (Y401F/
Y449F/Y456F). Our data suggest that TSLP-induced
STAT5 phosphorylation requires at least one cytoplas-
mic tyrosine residue in the human TSLP receptor com-
plex. We also examined JAK2 phosphorylation in cells
expressing wild type and various mutant receptors and
failed to detect any tyrosine phosphorylation induced by
TSLP (data not shown) in agreement with previous
reports [2,17,18].
Conclusions
Here we report that mutation of all four cytoplasmic
tyrosine residues in the TSLP receptor complex
abolishes the proliferative response to TSLP as well as
STAT5 phosphorylation. Mutation of individual tyrosine
residues in the cytoplasmic domain of human IL-7Ra or
TSLPR was not sufficient to abolish this proliferative
response although it did impair the response at low
doses of TSLP (1 ng/ml and 10 ng/ml). Intriguingly,
these mutations led to an increase in the proliferation
rate in response to high doses of TSLP (100 ng/ml).
Further experimentation will be required to elucidate
the mechanistic basis of the signals that are mediated by
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Page 5 of 11Figure 3 The cytoplasmic tyrosine residues of the human IL-7Ra are not required for TSLP-dependent cell proliferation. TSLP-induced
proliferation of Ba/F3 cells co-expressing the indicated receptors was examined as described in Figure 2D. The proliferative response to different
doses of TSLP was assessed in Ba/F3 cells expressing the indicated receptors as described in Figure 2E. Statistically significance was calculated
using Student’s t-test (* indicates a significant difference with p-value < 0.01; **p-value < 0.05). (The growth of cells was examined in 3
independent sets of experiments and found to be similar. The results from one representative experiment are shown).
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Page 6 of 11Figure 4 The cytoplasmic tyrosine residues of the human IL-7Ra are required for IL-7-dependent cell proliferation.( A )As c h e m a t i c
illustration of the human IL-7 receptor complex composed of the human IL-7Ra and the human gc. Y denotes the cytoplasmic tyrosine residues.
(B) IL-7-induced proliferation of various cell lines as indicated was examined as described in Fig. 2B. 100 ng/ml IL-7 was used. (C) Surface
expression of the wild type/mutated human IL-7Ra and human gc in the cell lines. Exponentially growing infected Ba/F3 cells were analyzed by
flow cytometry for cell surface expression of human IL-7Ra and gc. (The growth of cells was examined in 3 independent sets of experiments and
found to be similar. The results from one representative experiment are shown).
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Page 7 of 11Figure 5 TSLP-dependent cell proliferation requires the presence of at least one tyrosine residue. TSLP-induced proliferation of Ba/F3
cells co-expressing the indicated receptors was examined as described in Figure 2D. The proliferative response to different doses of TSLP was
assessed in Ba/F3 cells expressing the indicated receptors as described in Figure 2E. Statistically significance was calculated using Student’s t-test
(* indicates a significant difference with p-value < 0.01; **p-value < 0.05). (The growth of cells was examined in 3 independent sets of
experiments and found to be similar. The results from one representative experiment are shown).
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Page 8 of 11the TSLP receptor complex. In this regard, it is interest-
ing to note that the cytosolic tyrosine residues in IL-




PE-conjugated streptavidin, PE-conjugated anti-human
CD4, PE-conjugated anti-human gc, and Alexa Fluor®647
conjugated anti-human IL-7Ra antibodies were from
BD Biosciences Pharmingen (San Jose, CA, USA). Anti-
phosphotyrosine antibodies (HRP-conjugated) were
from Millipore (Billerica, MA, USA) and anti-Stat5a
antibodies were from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Recombinant mouse IL-3, recombinant
human IL-7, recombinant human TSLP and biotinylated
anti-human TSLPR antibodies were from R&D Systems
(Minneapolis, MN). RPMI 1640, fetal bovine serum
(FBS), L-glutamine, and antibiotics were purchased from
Invitrogen (Carlsbad, CA, USA). QuikChange XL-II
mutagenesis kit was from Stratagene (La Jolla, CA,
USA). Sequencing services were performed by the DNA
and Peptide Synthesis and Sequencing facility at Johns
Hopkins University School of Medicine using dye termi-
nator chemistry. All other reagents used in this study
were from Fisher Scientific (Pittsburgh, PA, USA).
Cell culture
The interleukin-3 (IL-3)-dependent pre B cell line,
Ba/F3, was grown in RPMI 1640 supplemented with
FBS, L-glutamine, penicillin, streptomycin, and mouse
recombinant IL-3 (10 ng/ml). Stably transfected Ba/F3
cell lines were grown in RPMI 1640 supplemented with
heat-inactivated FBS, L-glutamine, penicillin, streptomy-
cin and mouse recombinant IL-3 (10 ng/ml). Human
embryonic kidney 293T (HEK293T) cells were cultured
in Dulbecco modified essential medium, high glucose,
supplemented with FBS, L-glutamine, penicillin, and
streptomycin. Cell lines were maintained in the expo-
nential growth phase unless indicated otherwise.
Plasmids and expression vectors
The human TSLPR was obtained from Dr. James Ihle
[19]. The human IL-7Ra was subcloned into a bicistro-
nic retrovirus vector pMX-IRES-GFP [20] that expresses
GFP while the human TSLPR and gc were subcloned
into a bicistronic retrovirus vector pMX-IRES-hCD4
[20] that expresses the human CD4 antigen. The human
IL-7Ra, gc and TSLPR mutants were generated by site-
directed mutagenesis and confirmed by sequencing.
Generation of stable cell lines using retroviruses
HEK293T cells were transfected with the retroviral vec-
tor constructs (12 μg) together with the helper virus



















Figure 6 TSLP-induced STAT5 phosphorylation requires the presence of at least one cytoplasmic tyrosine residue. Exponentially
growing Ba/F3 cells expressing the indicated receptors were washed three times with RPMI 1640, deprived of IL-3, and then left untreated or
stimulated with recombinant human TSLP or mouse IL-3 as shown. After cell lysis, the cell lysates were subjected to immunoprecipitation using
anti-STAT5a antibodies. After washing, the immunoprecipitates were resolved by SDS-PAGE. The phosphorylation status of STAT5a was assayed
by Western blotting with anti-phosphotyrosine antibodies (4G10) and the total amount of Stat5a was measured by reprobing with anti-Stat5a
antibodies as indicated.
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Page 9 of 11using Lipofectamine 2000 (Invitrogen). Twenty-four
hours after transfection, the supernatants were harvested
and filtered through a 0.45-μm filter. Ba/F3 cells were
infected with the pairs of the human IL-7Ra in pMX-
IRES-GFP and the human TSLPR or gc in pMX-IRES-
hCD4. 48 hours after infection, Ba/F3 cells were stained
by PE-conjugated anti-human CD4 antibodies and then
sorted for GFP and the human CD4 expression.
Receptors cell surface expression
After sorting, exponentially growing Ba/F3 cells expres-
sing the pair of the wild type/mutated TSLP receptor
complex were washed twice, stained with biotinylated
anti-human TSLPR antibodies followed by PE-conju-
gated streptavidin and Alexa Fluor®647 conjugated anti-
human IL-7Ra and analyzed by flow cytometry. Simi-
larly, exponentially growing Ba/F3 cells expressing the
pair of the wild type/mutated IL-7 receptor complex
were washed twice, stained with PE-conjugated anti-
human gc, and Alexa Fluor®647 conjugated anti-human
IL-7Ra antibodies and analyzed by flow cytometry.
Immunoprecipitation and Western blotting
Exponentially growing Ba/F3 cells expressing different
combinations of receptors were washed three times with
RPMI 1640, deprived of IL-3 for 16 h, and then left
untreated or stimulated with recombinant human TSLP
or mouse IL-3 for 10 minutes at 37°C. Cells were lyzed
in modified RIPA buffer (50 mM Tris-HCl, pH 7.4, 150
mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 0.25%
sodium deoxycholate, and 1 mM sodium orthovanadate
in the presence of protease inhibitors) followed by cen-
trifugation. The supernatant was subjected to immuno-
precipitation using anti-Stat5a antibodies. After washing,
the immunoprecipitates were resolved by SDS-PAGE
and assayed by Western blotting with anti-phosphotyro-
sine antibodies (4G10) followed by reprobing with anti-
Stat5a antibodies.
Growth assays
The growth of cells expressing different combination of
receptors was examined in 3 independent sets of experi-
ments. In each experiment, exponentially growing Ba/F3
cells (in triplicate) expressing different combinations of
receptors were washed three times with RPMI 1640,
deprived of IL-3 for 16 h, and then stimulated with
recombinant human TSLP or IL-7. Living cells were
counted using a Beckman Coulter Z1 (Beckman Coul-
ter, Fullerton, CA, USA). The results (except where
indicated) are expressed as increase in cell number (sti-
mulation [n-fold]) as compared to the number of cells
plated on day 0. The mean and S.E.M were calculated
for each independent experiment. The results from the
three independent experiments were similar in each
case and one representative experiment is shown in the
figures.
Protein sequence alignments
The protein sequence alignments were performed using
ClustalX version 2.0.10 using the BLOSUM62 matrix.
Statistical analysis
Data were expressed as mean ± SEM. Differences were
examined by Student’s t-test between two groups.
p < 0.05 was considered significant.
List of abbreviations
TSLP: thymical stromal lymphopoietin; IL-7Ra: interleu-
kin-7 receptor a chain; TSLPR: TSLP receptor; gc: inter-
leukin-2 receptor g chain/common g chain.
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